https://inovio-marketing.aplusl.io/2024/01/inovio-plans-to-submit-a-bla-for-ino-3107-as-a-potential-treatment-for-rrp-in-second-half-of-2024-under-accelerated-approval-program/ 2024-01-22T19:38:42+00:00 https://inovio-marketing.aplusl.io/2024/01/inovio-and-coherus-announce-clinical-collaboration-to-advance-development-of-ino-3112-in-combination-with-loqtorzi-toripalimab-tpzi/ 2024-01-22T19:39:58+00:00 https://inovio-marketing.aplusl.io/2024/01/inovio-to-participate-in-virtual-fireside-chat-on-the-potential-treatment-of-recurrent-respiratory-papillomatosis-with-key-opinion-leader/ 2024-01-22T19:40:43+00:00 https://inovio-marketing.aplusl.io/2025/07/results-from-phase-1-2-study-of-ino-3107/ 2025-09-11T21:13:05+00:00